💊 Obat A-Z 🧬 Target 🛠 Alat 📚 Panduan
Semua Obat Kelas Obat Area Terapeutik Efek Samping
Panduan Glosarium Linimasa
Perbandingan Perjalanan Obat Famili Obat
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Sugar, Invert

CHEMBL1201647 Phase 4 Disetujui Unknown
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
360.3 g/mol
LogP
—
Phase
4

Invert sugar is a mixture of equal parts glucose and fructose produced by acid or enzymatic hydrolysis of sucrose, used as a pharmaceutical excipient, sweetener, and caloric carbohydrate source in parenteral and oral nutritional preparations. It is more hygroscopic and sweeter than sucrose due to the presence of fructose. In pharmaceutical applications, it provides readily metabolizable carbohydrate calories and serves as a vehicle and stabilizer for injectable preparations.

Berat Molekul

360,3100 g/mol

TPSA

236,00 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

SMILES

C(C(C(C(C(C=O)O)O)O)O)O.C(C(C(C(C(=O)CO)O)O)O)O

InChI

InChI=1S/2C6H12O6/c2*7-1-3(9)5(11)6(12)4(10)2-8/h3,5-9,11-12H,1-2H2;1,3-6,8-12H,2H2

Molecular Formula

C12H24O12

HBD / HBA

10 / 12

Ikatan yang Dapat Dirotasi

10

Atom Berat

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

Invert sugar is a mixture of equal parts glucose and fructose produced by acid or enzymatic hydrolysis of sucrose, used as a pharmaceutical excipient, sweetener, and caloric carbohydrate source in parenteral and oral nutritional preparations. It is more hygroscopic and sweeter than sucrose due to the presence of fructose. In pharmaceutical applications, it provides readily metabolizable carbohydrate calories and serves as a vehicle and stabilizer for injectable preparations.

Yes, Sugar, Invert is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201647. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 21924868. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.